Literature DB >> 23318735

Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge.

Maryam Piram1, Alfred Mahr.   

Abstract

PURPOSE OF REVIEW: To review the current knowledge of epidemiological features of immunoglobulin (Ig) A vasculitis (Henoch-Schönlein) and disease etiology. RECENT
FINDINGS: The annual incidence of IgA vasculitis in the population is an estimated 3-26.7/100 000 for children and infants and 0.8-1.8/100 000 for adults. These may be conservative approximations of the true frequency because of skewed case-finding strategies. In children, the marked autumn-winter peak in incidence rates, the frequent occurrence after an upper respiratory tract infection and the short interval between disease onset in index cases and in other family members collectively point to a transmissible infectious process. A subset of adult IgA vasculitis could be related to preceding or concurrent malignancies. Despite several lines of evidence supporting the critical role of an exogenous factor in IgA vasculitis, recent progress has been made in understanding the genetic susceptibility to IgA vasculitis. Recent findings also lessened the suggestion that IgA vasculitis might be triggered by vaccination.
SUMMARY: IgA vasculitis is two to 33 times more common in children than adults and appears to have a strong environmental component, with possibly different risk factors in childhood and adulthood. Support is strengthening for a role of genetics in IgA vasculitis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23318735     DOI: 10.1097/BOR.0b013e32835d8e2a

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  59 in total

1.  Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota.

Authors:  Amrita Arora; David A Wetter; Tania M Gonzalez-Santiago; Mark D P Davis; Christine M Lohse
Journal:  Mayo Clin Proc       Date:  2014-06-27       Impact factor: 7.616

2.  IgA nephropathy with diffuse alveolar haemorrhage.

Authors:  Shinichi Miyazaki; Akiko Hattori; Yasumasa Kuno; Takuya Ikeda
Journal:  BMJ Case Rep       Date:  2018-12-22

Review 3.  Childhood- Versus Adult-Onset Primary Vasculitides: Are They Part of the Same Clinical Spectrum?

Authors:  Renato Ferrandiz-Espadin; Manuel Ferrandiz-Zavaler
Journal:  Curr Rheumatol Rep       Date:  2019-08-29       Impact factor: 4.592

4.  Urinary MCP-1/creatinine in Henoch-Schönlein purpura and its relationship with nephritis.

Authors:  Yolanda Fuentes; Ana María Hernández; Pilar García-Roca; Saúl Valverde; Luis Fernando Velásquez-Jones; Germán Sosa; Uriel Oswaldo Duarte-Durán; Lourdes Ortíz; Rocío Maldonado; Enrique Faugier; Guillermo Ramón-García; Mara Medeiros
Journal:  Pediatr Nephrol       Date:  2014-01-12       Impact factor: 3.714

Review 5.  An update on the role of epigenetics in systemic vasculitis.

Authors:  Patrick Coit; Haner Direskeneli; Amr H Sawalha
Journal:  Curr Opin Rheumatol       Date:  2018-01       Impact factor: 5.006

Review 6.  [Research advances in immunological pathogenesis of immunoglobulin A vasculitis].

Authors:  Ya-Ting Liu; Si-Guang Lu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-07

Review 7.  Autoinflammatory Disease-Associated Vasculitis/Vasculopathy.

Authors:  Mansour Alghamdi
Journal:  Curr Rheumatol Rep       Date:  2018-11-17       Impact factor: 4.592

8.  Adult Onset Henoch-Schonlein Purpura associated with a Metastatic Malignancy of Unknown Primary Origin.

Authors:  Therese Posas-Mendoza; Dayna Lucuab-Fegurgur; Jefferson Roberts
Journal:  Hawaii J Med Public Health       Date:  2018-10

Review 9.  [Skin diseases due to systemic vasculitides and vasculopathies].

Authors:  S Volc; J C Maier; M Röcken
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

Review 10.  Helicobacter pylori and skin autoimmune diseases.

Authors:  Eli Magen; Jorge-Shmuel Delgado
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.